Cervical Cancer Ranks Fourth Among Female Cancers
In 2022, around 660,000 new cases and 350,000 deaths were attributed to this. In India, it is the second most common cancer among women and the second most common cancer among women aged 15 to 44.
In 2022, around 660,000 new cases and 350,000 deaths were attributed to this. In India, it is the second most common cancer among women and the second most common cancer among women aged 15 to 44.
Regular cervical screening may help a person detect and treat indications of cancer before it develops or spreads too far. Screening does not identify cancer but alterations in the cervix's cells.
It is transmitted sexually on its own and can progress to precancerous cell alterations and, in rare cases, cervical cancer. Even if women have been vaccinated against HPV, they should undergo frequent Pap smears and HPV testing.
Along with the Pap test, it helps to detect the virus (human papillomavirus), which can alter the cells of the cervix and detect precancerous cell abnormalities on the cervix that, if not appropriately treated, can progress to cervical cancer.
A Pap smear is a painless process, and the surrounding region abnormalities may develop into cervical cancer. Screening guidelines for women aged 30 to 65 include pap smears every three years, high-risk HPV testing every five years, or a combination of the two every five years.
A person may not exhibit any symptoms. As a result, women should have frequent cervical smears, often known as Pap tests. A Pap test serves as a preventative measure to suggest the onset of cancer so that a person may take early action to treat it.